• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IA期肺腺癌术后复发危险因素分析

Analysis of risk factors for postoperative recurrence of stage IA lung adenocarcinoma.

作者信息

Xu Wendong, Li Runze, Tuerxun Dilihumaer, Wang Yuanguo, Li Jian, Li Jingyu, Zhang Peng

机构信息

Deparment of Cardiothoracic Surgery, Tianjin Medical University General Hospital Airport Hospital, Tianjin, China.

Deparment of Cardiothoracic Surgery, Tianjin Medical University General Hospital, Tianjin, China.

出版信息

Front Oncol. 2025 Aug 11;15:1557081. doi: 10.3389/fonc.2025.1557081. eCollection 2025.

DOI:10.3389/fonc.2025.1557081
PMID:40860799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12375638/
Abstract

OBJECTIVE

To explore the influencing recurrence in patients with stage IA lung adenocarcinoma following surgical resection.

METHOD

A retrospective analysis was conducted on the clinical and pathological data of patients with stage IA lung adenocarcinoma who underwent surgical resection in the Department of Thoracic Surgery at Tianjin Medical University General Hospital from January 1, 2018, to December 31, 2021. The Fine-Gray model was utilized for multivariate analysis to identify factors influencing the cumulative incidence of lung cancer recurrence. The hazard ratio (HR) and its 95% confidence interval (CI) were calculated.

RESULT

Among 475 patients, there were 30 cases of postoperative recurrence and metastasis. The results of the univariate analysis using the Gray test indicated that vascular invasion, STAS, solid and micropapillary patterns, pTNM classification, lymph node resection method, surgical method, organizational differentiation, CTR had a significant impact (P<0.05). The multivariate analysis revealed that pTNM classification, lymph node resection method, vascular invasion and the presence of solid or micropapillary patterns were significantly correlated.

CONCLUSION

Tumor staging, the presence of solid or micropapillary components in pathology, vascular invasion, and the method of lymph node resection significantly influence postoperative disease-free survival (DFS) in patients with stage IA lung adenocarcinoma undergoing surgical resection.

摘要

目的

探讨ⅠA期肺腺癌患者手术切除后影响复发的因素。

方法

回顾性分析2018年1月1日至2021年12月31日在天津医科大学总医院胸外科接受手术切除的ⅠA期肺腺癌患者的临床和病理资料。采用Fine-Gray模型进行多因素分析,以确定影响肺癌复发累积发生率的因素。计算风险比(HR)及其95%置信区间(CI)<0.05)。多因素分析显示,pTNM分期、淋巴结切除方式、血管侵犯以及实性或微乳头结构的存在显著相关。

结论

肿瘤分期、病理中实性或微乳头成分的存在、血管侵犯和淋巴结切除方式显著影响接受手术切除的ⅠA期肺腺癌患者术后无病生存期(DFS)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a6/12375638/3c275c5c0f3f/fonc-15-1557081-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a6/12375638/3c275c5c0f3f/fonc-15-1557081-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a6/12375638/3c275c5c0f3f/fonc-15-1557081-g001.jpg

相似文献

1
Analysis of risk factors for postoperative recurrence of stage IA lung adenocarcinoma.IA期肺腺癌术后复发危险因素分析
Front Oncol. 2025 Aug 11;15:1557081. doi: 10.3389/fonc.2025.1557081. eCollection 2025.
2
High-grade histological patterns in metastatic lymph nodes associated with poor prognosis in resected lung adenocarcinoma: a multicentre retrospective cohort study.转移性淋巴结中的高级别组织学模式与肺腺癌切除术后预后不良相关:一项多中心回顾性队列研究
Pathology. 2025 May 31. doi: 10.1016/j.pathol.2025.03.012.
3
Preoperative Prognosis Prediction for Pathological Stage IA Lung Adenocarcinoma: 3D-Based Consolidation Tumor Ratio is Superior to 2D-Based Consolidation Tumor Ratio.病理分期为IA期肺腺癌的术前预后预测:基于三维的实变肿瘤比率优于基于二维的实变肿瘤比率。
Acad Radiol. 2025 Sep;32(9):5567-5575. doi: 10.1016/j.acra.2025.05.040. Epub 2025 Jun 6.
4
Tumor Spread Through Air Spaces Is a Predictor of Occult Lymph Node Metastasis in Clinical Stage IA Lung Adenocarcinoma.空气传播肿瘤是临床 IA 期肺腺癌隐匿性淋巴结转移的预测因子。
J Thorac Oncol. 2020 May;15(5):792-802. doi: 10.1016/j.jtho.2020.01.008. Epub 2020 Jan 30.
5
The extent of lymph node dissection is not associated with disease-free survival following lobar or sublobar resection: results from CALGB 140503 (Alliance).肺叶或肺段切除术后淋巴结清扫范围与无病生存期无关:CALGB 140503(联盟)研究结果
J Thorac Cardiovasc Surg. 2025 Jun 16. doi: 10.1016/j.jtcvs.2025.06.007.
6
Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.内镜及手术切除 T1a/T1b 食管肿瘤:系统评价。
World J Gastroenterol. 2013 Mar 7;19(9):1424-37. doi: 10.3748/wjg.v19.i9.1424.
7
Sublobar resection is non-inferior to lobectomy in octogenarians and older with stage Ia non‑small cell lung cancer.对于患有Ia期非小细胞肺癌的八旬及以上老人,肺段切除术并不逊色于肺叶切除术。
Transl Cancer Res. 2025 May 30;14(5):2966-2980. doi: 10.21037/tcr-2024-2575. Epub 2025 May 14.
8
Association of cholesterol and triglyceride levels with the recurrence of early-stage lung adenocarcinoma with micropapillary pattern.胆固醇和甘油三酯水平与早期微乳头型肺腺癌复发的相关性
Transl Lung Cancer Res. 2025 Jul 31;14(7):2437-2451. doi: 10.21037/tlcr-2025-118. Epub 2025 Jul 10.
9
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
10
Impacts of thoracoscopic surgery and high grade histologic subtypes on spread through air spaces in small stage I lung adenocarcinomas.胸腔镜手术和高级别组织学亚型对Ⅰ期小肺癌腺癌细胞经气道播散的影响。
J Cancer Res Clin Oncol. 2019 Sep;145(9):2375-2382. doi: 10.1007/s00432-019-02972-6. Epub 2019 Jul 10.

本文引用的文献

1
State and Regional Trends in Incidence and Early Detection of Lung Cancer Among US Adults, 2010-2020.2010 - 2020年美国成年人肺癌发病率及早期发现的州和地区趋势
Prev Chronic Dis. 2024 Jul 25;21:E55. doi: 10.5888/pcd21.240016.
2
Cancer incidence and mortality in China, 2022.2022年中国癌症发病率与死亡率
J Natl Cancer Cent. 2024 Feb 2;4(1):47-53. doi: 10.1016/j.jncc.2024.01.006. eCollection 2024 Mar.
3
Refining Colon Cancer Screening, Antibody Therapy for Lung Cancer, and More-Highlights From ASCO 2024.
JAMA. 2024 Aug 13;332(6):444-446. doi: 10.1001/jama.2024.10371.
4
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
5
Screening for lung cancer: 2023 guideline update from the American Cancer Society.肺癌筛查:美国癌症协会 2023 年指南更新。
CA Cancer J Clin. 2024 Jan-Feb;74(1):50-81. doi: 10.3322/caac.21811. Epub 2023 Nov 1.
6
[Chinese expert consensus on diagnosis of early lung cancer (2023 Edition)].《中国早期肺癌诊断专家共识(2023年版)》
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Jan 12;46(1):1-18. doi: 10.3760/cma.j.cn112147-20220712-00592.
7
Reprint of "Introduction to 2021 WHO Classification of Thoracic Tumors".《2021年世界卫生组织胸肿瘤分类介绍》重印本
J Thorac Oncol. 2022 Mar;17(3):337-340. doi: 10.1016/j.jtho.2022.01.008.
8
Segmentectomy Provides Comparable Outcomes to Lobectomy for Stage IA Non-small Cell Lung Cancer with Spread through Air Spaces.对于伴有气腔播散的IA期非小细胞肺癌,肺段切除术与肺叶切除术的疗效相当。
Semin Thorac Cardiovasc Surg. 2023 Spring;35(1):156-163. doi: 10.1053/j.semtcvs.2022.02.001. Epub 2022 Feb 9.
9
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.中国和美国 2022 年癌症统计数据:概况、趋势和决定因素。
Chin Med J (Engl). 2022 Feb 9;135(5):584-590. doi: 10.1097/CM9.0000000000002108.
10
Immunotherapy for mesothelioma: Moving beyond single immune check point inhibition.间皮瘤的免疫疗法:超越单一免疫检查点抑制
Lung Cancer. 2022 Mar;165:91-101. doi: 10.1016/j.lungcan.2022.01.016. Epub 2022 Jan 25.